NCT00997308View on ClinicalTrials.gov

A Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD1446 Administered for 4 Weeks in Elderly Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Healthy
Interventions
DRUG

AZD1446

Solution, oral, for 4 weeks

DRUG

Placebo

Trial Locations (1)

Unknown

Research, Lund

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY